Literature DB >> 11237984

Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings.

A Rossi1, R Cerone, R Biancheri, R Gatti, M C Schiaffino, C Fonda, E Zammarchi, P Tortori-Donati.   

Abstract

BACKGROUND AND
PURPOSE: Combined methylmalonic aciduria and homocystinuria (MMA-HC) is caused by impaired hepatic conversion of dietary cobalamin to methylcobalamin and adenosylcobalamin, resulting in decreased activity of methylmalonyl-CoA mutase and methionine synthase. Patients with the early-onset variety present within 12 months of age with severe neurologic, hematologic, and gastrointestinal abnormalities. We describe the neuroradiologic features of early-onset MMA-HC and discuss related pathophysiological mechanisms.
METHODS: Twelve infants with hypotonia, failure to thrive, poor feeding, and hematologic abnormalities were diagnosed with MMA-HC on the basis of a typical plasmatic and urinary metabolic profile and enzyme activity in fibroblastic cultures. Complementation studies were performed in two cases, and yielded a CblC result. MR imaging was performed at presentation in four cases and later in the others. All patients showed prompt biochemical improvement with intramuscular hydroxocobalamin administration, and most had moderate neurologic improvement.
RESULTS: Diffuse supratentorial white matter edema and dysmyelination was the typical MR picture at presentation, whereas white matter bulk loss characterized later stages of the disease. Nucleocapsular areas of gliosis were an additional finding in one case. One patient had tetraventricular hydrocephalus at presentation.
CONCLUSION: White matter damage is probably caused by reduced methyl group availability and nonphysiological fatty acids toxicity, whereas focal gliosis results from homocysteine-induced toxicity to the endothelium. Hydrocephalus may result from diffuse intracranial extracerebral arterial stiffness, known as reduced arterial pulsation hydrocephalus. MR imaging features at presentation and at follow-up are nonspecific.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237984      PMCID: PMC7976836     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  Minor facial anomalies in combined methylmalonic aciduria and homocystinuria due to a defect in cobalamin metabolism.

Authors:  R Cerone; M C Schiaffino; U Caruso; S Lupino; R Gatti
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Ocular histopathologic characteristics of cobalamin C type vitamin B12 defect with methylmalonic aciduria and homocystinuria.

Authors:  E I Traboulsi; J C Silva; M T Geraghty; I H Maumenee; D Valle; W R Green
Journal:  Am J Ophthalmol       Date:  1992-03-15       Impact factor: 5.258

3.  CT and MR studies of methylmalonic acidemia.

Authors:  C F Andreula; R De Blasi; A Carella
Journal:  AJNR Am J Neuroradiol       Date:  1991 May-Jun       Impact factor: 3.825

4.  Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia.

Authors:  J C Peterson; J D Spence
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

5.  Neurological complications of hemolytic-uremic syndrome.

Authors:  J S Hahn; P L Havens; J J Higgins; P P O'Rourke; J A Estroff; R Strand
Journal:  J Child Neurol       Date:  1989-04       Impact factor: 1.987

6.  Progressive neurological deterioration and MRI changes in cblC methylmalonic acidaemia treated with hydroxocobalamin.

Authors:  G M Enns; A J Barkovich; D S Rosenblatt; D R Fredrick; K Weisiger; C Ohnstad; S Packman
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

7.  Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC).

Authors:  D S Rosenblatt; A L Aspler; M I Shevell; B A Pletcher; W A Fenton; M R Seashore
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

8.  Reliability of biochemical parameters used in prenatal diagnosis of combined methylmalonic aciduria and homocystinuria.

Authors:  B Merinero; C Pérez-Cerdá; M J Garcia; B Chadefaux-Vekemans; P Kamoun; C Tonetti; J Zittoun; C Jakobs; M Ugarte
Journal:  Prenat Diagn       Date:  1998-09       Impact factor: 3.050

9.  Neurological involvement in hemolytic-uremic syndrome.

Authors:  K J Sheth; H M Swick; N Haworth
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

10.  Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy.

Authors:  H Ogura; M Takaoka; M Kishi; M Kimoto; T Shimazu; T Yoshioka; H Sugimoto
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

View more
  22 in total

1.  Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China.

Authors:  Fei Wang; Lianshu Han; Yanling Yang; Xuefan Gu; Jun Ye; Wenjuan Qiu; Huiwen Zhang; Yafen Zhang; Xiaolan Gao; Yu Wang
Journal:  J Inherit Metab Dis       Date:  2010-10-06       Impact factor: 4.982

2.  An infant with methylmalonic aciduria and homocystinuria (cblC) presenting with retinal haemorrhages and subdural haematoma mimicking non-accidental injury.

Authors:  Peter J Francis; David M Calver; Peter Barnfield; Charles Turner; R Neil Dalton; Mike P Champion
Journal:  Eur J Pediatr       Date:  2004-04-09       Impact factor: 3.183

3.  Clinical images - a quarterly column: subacute combined degeneration of the spinal cord.

Authors:  Richard Marshall; James Michael Milburn
Journal:  Ochsner J       Date:  2013

4.  Hydrocephalus in cblC type methylmalonic acidemia.

Authors:  Kaihui Zhang; Min Gao; Guangyu Wang; Yingying Shi; Xiaoying Li; Yvqiang Lv; Guangye Zhang; Zhongtao Gai; Yi Liu
Journal:  Metab Brain Dis       Date:  2018-12-19       Impact factor: 3.584

5.  Response to: 'Methylcobalamine is effective in peripheral neuropathies'.

Authors:  K Thakkar; G Billa
Journal:  Eur J Clin Nutr       Date:  2015-01-21       Impact factor: 4.016

Review 6.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

Review 7.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.

Authors:  Nuria Carrillo-Carrasco; Randy J Chandler; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

8.  Cognitive and social profiles in two patients with cobalamin C disease.

Authors:  M H Beauchamp; V Anderson; A Boneh
Journal:  J Inherit Metab Dis       Date:  2009-10-15       Impact factor: 4.982

9.  Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder.

Authors:  D S Froese; S Healy; M McDonald; G Kochan; U Oppermann; F H Niesen; R A Gravel
Journal:  Mol Genet Metab       Date:  2010-02-15       Impact factor: 4.797

10.  Vitamin B12 deficiency neurological syndromes: correlation of clinical, MRI and cognitive evoked potential.

Authors:  J Kalita; U K Misra
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.